Fifteen patients with secondary progressive multiple sclerosis (MS) showed stability in lesion load, brain activity, and clinical and laboratory outcomes, with no serious adverse events, 12 months after receiving an injection of human stem...
Fifteen patients with secondary progressive multiple sclerosis (MS) showed stability in lesion load, brain activity, and clinical and laboratory outcomes, with no serious adverse events, 12 months after receiving an injection of human stem...
Fifteen patients with secondary...